Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-interferon and multiple sclerosis

G L Hall1, A Compston, N J Scolding

  • 1University of Cambridge Neurology Unit, Addenbrooke's Hospital, UK.

Trends in Neurosciences
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?

Practical neurology·2022
Same author

Amyloid cerebrovasculopathies.

Practical neurology·2022
Same author

Factors affecting mortality after traumatic brain injury in a resource-poor setting.

BJS open·2020
Same author

An urgent need for African spirometry reference equations: the Paediatric and Adult African Spirometry study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Deep or awake removal of laryngeal mask airway in children at risk of respiratory adverse events undergoing tonsillectomy-a randomised controlled trial.

British journal of anaesthesia·2018
Same author

Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children.

British journal of anaesthesia·2017
Same journal

Emulating the periodic table: A unified list of CNS terms and abbreviations for humans and experimental animals.

Trends in neurosciences·2026
Same journal

From chromatin dynamics to brain disease: Polycomb-Trithorax mechanisms in neurodevelopment.

Trends in neurosciences·2026
Same journal

Striatum regulates the cortex via the basal forebrain cholinergic system: A role for substance P.

Trends in neurosciences·2026
Same journal

A large brain adds new types of neurons: Molecular and functional signatures of spindle neurons in the human neocortex.

Trends in neurosciences·2026
Same journal

Exercise as a regulator of glymphatic function.

Trends in neurosciences·2026
Same journal

The neural basis of laughter.

Trends in neurosciences·2026
See all related articles

Interferon-beta (IFN-beta) is the first treatment to impact multiple sclerosis (MS) progression. This review examines IFN-beta mechanisms in demyelinating disease and proposes a treatment model for MS.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is an inflammatory CNS disease affecting its natural course.
  • Interferon-beta (IFN-beta) was the first therapeutic intervention approved for relapsing-remitting MS.
  • Despite initial optimism, treatment limitations and costs have tempered patient expectations as IFN-beta is not a cure.

Purpose of the Study:

  • To review the known mechanisms of action for IFN-beta in demyelinating diseases.
  • To propose a potential model for IFN-beta's action in treating MS.

Main Methods:

  • Literature review of existing studies on IFN-beta and MS.
  • Analysis of clinical trial data and treatment outcomes.
  • Synthesis of information to propose a mechanistic model.

Related Experiment Videos

Main Results:

  • IFN-beta modulates the immune response in the CNS.
  • The precise mechanisms underlying IFN-beta's efficacy in MS remain under investigation.
  • A proposed model integrates current understanding of IFN-beta's effects.

Conclusions:

  • IFN-beta offers a degree of disease modification in MS but is not a cure.
  • Further research is needed to fully elucidate IFN-beta's mechanisms of action.
  • Understanding these mechanisms can refine treatment strategies for MS.